The Peptides And Macrocycle Drug Discovery Services Market Is Estimated To Be Worth USD 1.5 Billion In 2030, Predicts Roots Analysis

>

The peptides and macrocycle drug discovery services market is estimated to be worth USD 1.5 billion in 2030, predicts Roots Analysis

Given the recent developments in healthcare, supporting safety and efficacy of peptide and affiliated macrocycle drugs, the industry is presently witnessing an increase in discovery and development initiatives related to such therapeutic modalities.
Roots Analysis has announced the addition of “Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020-2030” report to its list of offerings.
The report features an extensive study on the current market landscape and future of companies offering services for peptides and macrocycle drug discovery operations. The study includes in-depth analyses, highlighting the capabilities of various service / technology providers engaged in this market. Amongst other elements, the report includes:

  • A detailed assessment of the current market landscape of companies offering peptide and macrocycle drug discovery services
  • An insightful geographical benchmarking of the capabilities of companies of various sizes, highlighting the key focus areas, comparing their existing strengths both within and beyond their respective peer groups (based on geography and company size).
  • An in-depth analysis of peptide platform and library service providers, featuring information on their company details, purpose of the platform, type of peptide manufactured and platform access model.
  • Profiles of peptides and macrocycle drug discovery service providers, featuring information on the year of establishment, location of headquarters, peptide discovery service / platform portfolio, recent developments, and an informed future outlook.
  • An analysis of the partnerships that have been established in the recent past, covering mergers and acquisitions, research collaborations, R&D agreements, licensing agreements (related to both technology platforms and service providers) and other form of collaborations.
  • An analysis of proprietary display technologies developed by different drug discovery technology providers, based on the 2X2 matrix.
  • A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

Key geographical regions
Europe
North America
Asia-Pacific and the Rest of the World

Key companies covered in the report

  • GenScript
  • JPT Peptide Technologies
  • CPC Scientific
  • IRBM
  • Creative Peptides
  • Pepscan
  • Interprotein
  • RA Pharmaceuticals
  • Pepticom
  • PeptiDream
  • Creative Biolabs
  • MeSCue-Janusys

For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html
Other Recent Offerings

About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
 

The next generation immune checkpoint inhibitors and stimulators market is projected to grow at an annualized rate of ~10.5%, till 2030
Roots Analysis has done a detailed study on Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
To order this 180+ page report, which features 90+ figures and 85+ tables, please visit this link
Key Market Insights 

  • More than 35 industry players claim to offer services for the identification, characterization and development of peptides and macrocycle-based pharmacological lead candidates
  • Several technology developers have made significant contributions in terms of developing novel platforms, based on a variety of innovative approaches, for the discovery of peptide-based drugs and macrocyclic molecules.
  • Service providers are expanding their capabilities in order to enhance their respective portfolios; display libraries have emerged the most popular platforms.
  • In recent years, a steady increase in partnership activity has been observed, resulting in the establishment of a variety of deals related to different types of peptides and macrocycles.
  • Drug developers are likely to continue to outsource discovery stage operations for therapeutic peptides and macrocyclic drugs in mid to long term, resulting in multi-billion growth for contract service providers.
  • Given the recent developments in healthcare, supporting safety and efficacy of peptide and affiliated macrocycle drugs, the industry is presently witnessing an increase in discovery and development initiatives related to such therapeutic modalities.

For more information, please visit https://www.rootsanalysis.com/reports/view_document/peptides-and-macrocycle-discovery/300.html
 
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com

Share:

Keywords: biotech,pharma,analysis,rotsanalysis,market

Comments

Other related blogs

The “Prefilled Syringe Fill / Finish Service Providers, 2020-2030” report features an extensive study of the current market

By : Roots Analysis

Key Inclusions A detailed review of the overall landscape of companies offering contract fill / f..


The prefilled syringe fill / finish services market is projected to grow at an annualized rate of over 10%, till 2030

By : Roots Analysis

Roots Analysis has done a detailed study on Prefilled Syringe Fill / Finish Services Market, 2020-20..


The prefilled syringe fill / finish services market is estimated to is estimated to reach close to USD 3 Billion by 2030

By : Roots Analysis

The numerous benefits offered by prefilled syringes, coupled to the growing self-medication trend, h..